Anti-CD22 (Mozistobart biosimilar) mAb (HDBS0622)
- SKU:
- HDBS0622
- Antibody Type:
- Biosimilar Reference Antibody
- Applications:
- IHC
- FC
- Drug Development
- Pharmacokinetics
- Disease Area:
- Cancer
- Size:
- 100 μg
- Target:
- CD22
- Isotype:
- IgG1
- Host Species:
- Whole mAb
- Reactivity:
- Human
Description
| Product Name: | Anti-CD22 (Mozistobart biosimilar) mAb |
| SKU: | HDBS0622 |
| Size: | 100 μg |
| Target: | CD22 |
| Common Name: | TAC001;TAC-001;TAC 001 |
| Isotype: | IgG1 |
| Host Species: | Whole mAb |
| Reactivity: | Human |
| Synonyms: | SIGLEC2;SIGLEC-2 |
| Conjugate: | Unconjugated |
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
| Uniprot: | P20273 |
| Formulation & Reconstitution: | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
| Usage: | Research use only |
| Storage & Shipping: | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
Related Products
Biotinylated Anti-CD22 (Mozistobart biosimilar) mAb (HDBS0991)
€429
Anti-CD22 (Suciraslimab biosimilar) mAb (HDBS0725)
€429
Biotinylated Anti-CD22 (Suciraslimab biosimilar) mAb (HDBS1094)
€429
Biotinylated Anti-CD22 (Pinatuzumab biosimilar) mAb (HDBS0245)
€429
Pinatuzumab Biosimilar (Anti-CD22) Antibody (HDBS0029)
€399